Streetbeat News

Revenues

THC

Tenet Healthcare Corporation (THC) has agreed to sell two hospitals in San Luis Obispo County to Adventist Health for approximately $550 million. Additionally, Tenet's Conifer Health Solutions will provide revenue cycle services to Adventist Health. The sale includes Sierra Vista Regional Medical Center and Twin Cities Community Hospital, along with affiliated physician practices.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 11:46 am

TSLA

Tesla Inc (NASDAQ:TSLA) is accused by a local water authority near its German Gigafactory in Grünheide of polluting Berlin's drinking water with hazardous pollutants exceeding permitted levels. Despite warnings, Tesla has not addressed the pollution issues. This adds to Tesla's challenges in Germany, including opposition to its expansion plans. Tesla aims to double the plant's capacity for battery and car production, but faces environmental and community concerns.

Portfolio Pulse from Anan Ashraf

February 29, 2024 | 11:46 am

CVEO

Civeo projects its FY24 revenues to be between $625M-$700M, surpassing the $623.11M estimate. The company also anticipates adjusted EBITDA to range from $80M-$90M and plans for capital expenditures of $30M-$35M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 11:40 am

TTE

TotalEnergies SE (NYSE:TTE) has signed a 16-year sale and purchase agreement with Sembcorp Fuels to deliver up to 0.8 million tons of LNG annually starting in 2027. This deal builds on an existing agreement running until 2029. Additionally, TotalEnergies recently announced partnerships for methane emission detection in India and a majority stake acquisition in the Tungsten Explorer drillship. The company also reported a revenue of $59.237 billion for Q4 FY23, surpassing estimates, despite a 12% decline in hydrocarbon production, and increased its quarterly dividends by 7.1% to €0.79.

Portfolio Pulse from Lekha Gupta

February 29, 2024 | 11:39 am

CVEO

Civeo reported Q4 sales of $170.80 million, surpassing the analyst consensus estimate of $151.12 million by 13.02%, and marking a 5.31% increase from the same period last year. The company also reported having cash and equivalents of $3.32 million at the end of Q4.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 11:37 am

UTZ

Utz Brands has projected its FY24 outlook with an expected organic net sales growth of approximately 3% or better, alongside an adjusted EPS growth of 16% to 21%.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 11:37 am

ENVB

Enveric Biosciences (NASDAQ:ENVB) has signed three non-binding term sheets with an undisclosed biotech company for the out-licensing of three classes of compounds from its drug portfolio for mental health treatments. These agreements include exclusive, royalty-bearing global licenses, cash buyout options, and future rights to related assets. The compounds, part of Enveric's over 1,000 novel molecules, are aimed at treating depression, anxiety, and addiction disorders. The potential licensing deals could bring Enveric up to $200 million in milestone payments and fees, plus royalties ranging from 2.5% to 10% on future sales.

Portfolio Pulse from Lara Goldstein

February 29, 2024 | 11:35 am

BKKT

Bakkt has released its Q4 preliminary report, showcasing revenues between $213M-$215M and gross crypto revenues of $197M-$199M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 11:32 am

GOLF

Acushnet Holdings forecasts FY24 consolidated net sales to be between $2.45B and $2.50B, closely aligning with the $2.46B estimate. The company also anticipates its adjusted EBITDA to range from $385M to $405M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 11:17 am

MNTX

Manitex International projects its FY24 revenues to be between $300M-$310M, aligning closely with the estimated $305.6M. The company also forecasts its adjusted EBITDA to range from $30M-$34M.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 11:12 am